Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (321-330 of 451) with videos related to

Pageof 46
Sort By:
Acta Neuropathologica|January 27, 2017
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoStefan Pusch, Sonja Krausert, Viktoria Fischer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System GliomaFlorian Iser, Felix Hinz, Dirk C Hoffmann, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Acta Neuropathologica|November 30, 2019
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic markerAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Acta Neuropathologica|March 14, 2025
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10Steffen Hirsch, Ramin Rahmanzade, Kerstin Grund, et al.
Brain Pathology (Zurich, Switzerland)|November 18, 2014
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profilesChristian Koelsche, Volker Hovestadt, David T W Jones, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
The Lancet. Oncology|April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective studyPhilipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Nature Cancer|January 29, 2025
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnosticsMichael Ritter, Christina Blume, Yiheng Tang, et al.
Pageof 46

Showing results (321-330 of 451) with videos related to

Sort By:
Pageof 46
Acta Neuropathologica|January 27, 2017
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoStefan Pusch, Sonja Krausert, Viktoria Fischer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System GliomaFlorian Iser, Felix Hinz, Dirk C Hoffmann, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Acta Neuropathologica|November 30, 2019
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic markerAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Acta Neuropathologica|March 14, 2025
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10Steffen Hirsch, Ramin Rahmanzade, Kerstin Grund, et al.
Brain Pathology (Zurich, Switzerland)|November 18, 2014
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profilesChristian Koelsche, Volker Hovestadt, David T W Jones, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
The Lancet. Oncology|April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective studyPhilipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Nature Cancer|January 29, 2025
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnosticsMichael Ritter, Christina Blume, Yiheng Tang, et al.
Pageof 46